发明名称 MEDICINAL COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide a medicinal composition containing a pyrazole compound having a CB1 receptor-antagonizing action as an active ingredient. SOLUTION: This medicinal composition comprises a compound represented by general formula [I] (wherein, R<SP>1</SP>and R<SP>2</SP>are a substituted or non-substituted aryl group or the like; R<SP>3</SP>is an alkyl group, or the like; E is amide group, carbamoyl group, or the like, or a substituent containing a heterocyclic compound such as furan, pyridine, morpholine, oxadiazole, or thiadiazole) or its pharmacologically acceptable salt as an active ingredient. COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2008285481(A) 申请公布日期 2008.11.27
申请号 JP20080108646 申请日期 2008.04.18
申请人 MITSUBISHI TANABE PHARMA CORP 发明人 MORITANI YASUNORI;IMASHIRO RITSUO;SATO ATSUSHI
分类号 A61K31/415;A61K31/4155;A61K31/4162;A61K31/422;A61K31/4245;A61K31/427;A61K31/4439;A61K31/454;A61K31/496;A61K31/497;A61K31/506;A61K31/5377;A61K31/541;A61P1/04;A61P1/08;A61P1/12;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P11/06;A61P13/02;A61P15/08;A61P17/02;A61P25/00;A61P25/02;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P25/36;A61P27/06;A61P29/00;A61P31/04;A61P31/12;A61P35/00;A61P43/00;C07D231/22;C07D401/12;C07D401/14;C07D403/12;C07D405/12;C07D409/12;C07D413/04;C07D413/12;C07D417/06;C07D417/12;C07D417/14;C07D487/10 主分类号 A61K31/415
代理机构 代理人
主权项
地址